ArticleInfection & chemotherapy2021

Ruxolitinib and the Mitigation of Severe COVID-19: A Systematic Review and Meta-analysis.

Jorge R Quiros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.